The FDA's decision to limit Covid vaccines to high-risk groups stirs controversy but aims to protect the most vulnerable. A pivotal change in public health.
NYSE American alerts SRx Health Solutions for missing Q2 2025 filing, granting a 6-month cure period. The company remains confident in regaining compliance.